NeuroMetrix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NeuroMetrix and buy or sell other stocks, ETFs, and their options commission-free!About NURO
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. Its products include DPNCheck, Quell, and ADVANCE system.
CEODaniel S. Goldberger
CEODaniel S. Goldberger
Employees13
Employees13
HeadquartersWoburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded1996
Founded1996
Employees13
Employees13
NURO Key Statistics
Market cap9.39M
Market cap9.39M
Price-Earnings ratio-1.14
Price-Earnings ratio-1.14
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.73
52 Week high$4.73
52 Week low$3.22
52 Week low$3.22
Stock Snapshot
NeuroMetrix(NURO) stock is priced at $4.58, giving the company a market capitalization of 9.39M. It carries a P/E multiple of -1.14.
During the trading day, NeuroMetrix(NURO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for NeuroMetrix(NURO) stock has reached 0.
Over the past 52 weeks, NeuroMetrix(NURO) stock has traded between a high of $4.73 and a low of $3.22.
Over the past 52 weeks, NeuroMetrix(NURO) stock has traded between a high of $4.73 and a low of $3.22.
People also own
Based on the portfolios of people who own NURO. This list is generated using Robinhood data, and it’s not a recommendation.